Chief Executive Officer
Pantec Biosolutions AG
The target component to address in this case is the epidermis. The hand held device creates the micro-pores. They can control the accurate array of micro-pores. It’s without pain and causes small amounts of damage. It is independent of the skin condition.
Regulatory and intellectual property estate. One product: IVF001, IVF002, both for infertility. They can get the protein across the skin at therapeutic levels. The protein can be delivered from the patch at therapeutic concentrations.
The delivery of vaccines – application of ovalbumin using P.L.E.A.S.E. ® lead to activation of APCs. The immunization with recombinant proteins using please is superior to interdermal needle injection.
|
Share this article with your social network, just click below to share now!
|
|
|








No comments :
Post a Comment